Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. High-risk patients have still a poor prognosis despite the therapeutic progress. The aim of this study is to assess by Magnetic Resonance Imaging (MRI) the physiological changes (perfusion and hypoxia) induced by an experimental anticancer therapy tested in a well-characterized preclinical transgenic neuroblastoma murine model. Our results show a decrease of the Ktrans parameter and relaxivity R2* value in treated mice compared to control, suggesting an impact of such therapy on vessels normalization.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords